Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

K Patel, SK Asrani, MI Fiel, D Levine, DH Leung… - Hepatology, 2025 - journals.lww.com
Hepatology AASLD Publications Hepatology Liver Transplantation Hepatology
Communications Clinical Liver Disease Log in or Register Subscribe to journalSubscribe Get …

SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum

Y Kamada, T Nakamura, S Isobe, K Hosono… - Journal of …, 2023 - Springer
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease.
Nonalcoholic steatohepatitis (NASH) is an advanced form of NAFLD can progress to liver …

Development and validation of hepamet fibrosis scoring system–a simple, noninvasive test to identify patients with nonalcoholic fatty liver disease with advanced …

J Ampuero, R Pais, R Aller, R Gallego-Durán… - Clinical …, 2020 - Elsevier
Background & Aims Fibrosis affects prognoses for patients with nonalcoholic fatty liver
disease (NAFLD). Several non-invasive scoring systems have aimed to identify patients at …

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

E Blond, E Disse, C Cuerq, J Drai, PJ Valette, M Laville… - Diabetologia, 2017 - Springer
Aims/hypothesis We aimed to assess the application of the recent European Association for
the Study of the Liver (EASL)–European Association for the Study of Diabetes (EASD) …

Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index …

F Eren, E Kaya, Y Yilmaz - European journal of gastroenterology & …, 2022 - journals.lww.com
Methods A total of 560 patients (28 lean, 174 overweight, 229 obese, 89 severely obese, 40
morbidly obese) were included. Diagnostic performances and optimal cut-off values for FIB …

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity

A Drolz, S Wolter, MH Wehmeyer, F Piecha… - International journal of …, 2021 - nature.com
Background Non-invasive scores, such as the non-alcoholic fatty liver disease (NAFLD)
Fibrosis Score (NFS), are increasingly used for liver fibrosis assessment in patients with …

[HTML][HTML] Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American …

R Zambrano-Huailla, L Guedes, JT Stefano… - Annals of hepatology, 2020 - Elsevier
Introduction and aims Several non-invasive scoring systems have been developed and
validated worldwide to predict the risk of liver fibrosis in nonalcoholic fatty liver disease …

Accuracy of FIB-4 to detect elevated liver stiffness measurements in patients with non-alcoholic fatty liver disease: a cross-sectional study in referral centers

M Viganò, N Pugliese, F Cerini, F Turati… - International Journal of …, 2022 - mdpi.com
The identification of advanced fibrosis by applying noninvasive tests is still a key component
of the diagnostic algorithm of NAFLD. The aim of this study is to assess the concordance …

[HTML][HTML] Accuracy of noninvasive scoring systems in assessing liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis

S Han, M Choi, B Lee, HW Lee, SH Kang, Y Cho… - Gut and …, 2022 - ncbi.nlm.nih.gov
Methods For this meta-analysis, various databases including PubMed (MEDLINE),
EMBASE, OVID Medline and the Cochrane Library were systematically searched. After the …

The utility and diagnostic accuracy of transient elastography in adults with morbid obesity: a prospective study

AH Ali, A Al Juboori, GF Petroski, AA Diaz-Arias… - Journal of Clinical …, 2022 - mdpi.com
Patients with morbid obesity are at high risk for nonalcoholic fatty liver disease (NAFLD)
complicated by liver fibrosis. The clinical utility of transient elastography (TE) by Fibroscan in …